The Patent Finder

Macrophage Pharma Limited

Also on record
Records under this name other than patents Macrophage Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 7 of 7 · Back to Macrophage Pharma Limited

PatentTitleStatus Expires Confidence
US 8,778,953Inhibitors of P38 Map Kinase
Lapsed on the fee record
Ended Jul 15, 2026 · High confidence
Lapsed on the fee recordEnded Jul 15, 2026High confidence
US 11,382,902Treatment of Cancer by Stimulation of IL-12 Production
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 9,896,417Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof
Lapsed on the fee record
Ended Feb 20, 2026 · From the USPTO record
Lapsed on the fee recordEnded Feb 20, 2026From the USPTO record
US 9,388,136Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof
Lapsed on the fee record
Ended Jul 12, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jul 12, 2024From the USPTO record
US 8,044,211P38 MAP kinase inhibitors
Lapsed on the fee record
Ended Oct 25, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 25, 2023From the USPTO record
US 10,370,332Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof
Lapsed on the fee record
Ended Aug 6, 2023 · From the USPTO record
Lapsed on the fee recordEnded Aug 6, 2023From the USPTO record
US 9,604,9402-aminopyrazine derivatives as CSF-1R kinase inhibitors
Lapsed on the fee record
Ended Mar 28, 2021 · From the USPTO record
Lapsed on the fee recordEnded Mar 28, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited